New severe asthma biomarkers linked to lipid oxidation may transform non-invasive disease monitoring and treatment strategies. Read more.
Treating Severe Uncontrolled Asthma: Can Single-Inhaler, Fixed Triple-Dose Therapy Improve Outcomes?
Most people with asthma can be effectively managed with an inhaled corticosteroid (ICS), alone or in combination with a long-acting β2-agonist (LABA). However, a significant number of patients with ...
Substantial progress has been made in the understanding and management of patients with asthma in recent years, yet this heterogeneous disease still poses an unacceptable health burden globally. The ...
Granzyme K (GzmK), a family of granzymes implicated in age-associated inflammatory disease, plays a key role in driving chronic inflammation by causing cell death. Despite its significant impact on ...
ABSTRACT: Background: Carbocysteine is a mucoregulatory agent with anti-inflammatory properties used in chronic respiratory and otorhinolaryngological diseases. However, clinical evidence across ...
Esther Bejarano's son was 11 months old when asthma landed him in the hospital. She didn't know what had triggered his symptoms — neither she nor her husband had asthma — but she suspected it was the ...
Stephen Hughes receives research grant funding from the Australian Government Department of Health and Aged Care Medical Research Future Fund, The Australian Research Council and Asthma Australia. He ...
Panelists discusses how the "vicious vortex model" explains bronchiectasis pathophysiology, where airway dilatation leads to mucus stagnation, chronic infections, and neutrophilic inflammation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results